Form 4: GoodRx CFO Christopher McGinnis Equity Transaction

GoodRx Holdings CFO Christopher McGinnis acquired 36,987 shares via RSU vesting and disposed of 10,745 shares for tax obligations.

Summary

• Christopher A. McGinnis, Chief Financial Officer & Treasurer of GoodRx Holdings, Inc., reported the vesting of 36,987 restricted stock units (RSUs).
• The transaction occurred on April 15, 2026.
• 10,745 shares were withheld by the company to satisfy tax withholding obligations at a price of $2.23 per share.
• Following these transactions, the reporting person holds 152,563 shares of Class A Common Stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative event related to executive compensation, carrying no material signal regarding the company's operational outlook.

Positives

• The transaction reflects the ongoing vesting of equity compensation, aligning the CFO's interests with long-term shareholder value.

Negatives

• The disposal of 10,745 shares was required to cover tax liabilities associated with the RSU vesting.

Risks

• Continued service requirements are necessary for the remaining 406,865 unvested restricted stock units to vest.

Future Outlook

The remaining 406,865 restricted stock units are scheduled to vest in 12 equal quarterly installments, subject to the reporting person's continued service.

Industry Context

StockSavvy.ai notes that routine equity vesting and tax-related share withholding are standard corporate governance practices for executive compensation and do not typically signal a change in management sentiment regarding company performance.

Comparison to Industry Standards

• The transaction follows standard SEC reporting requirements for executive equity compensation.
• Tax withholding via share cancellation is a common practice among publicly traded technology and healthcare companies.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation event.

Next Steps

• Continued quarterly vesting of remaining restricted stock units.

Key Dates

Keywords

GoodRx, GDRX, Insider Trading, Form 4, Equity Compensation, CFO